Latest Breaking News On - Bart bandy - Page 6 : comparemela.com

ReShape Lifesciences Inc.: ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results Recent Highlights and Accomplishments Entered into a definitive merger agreement with Obalon Therapeutics, Inc., a company focused on developing and commercializing novel technologies for weight loss. Strategic merger provides market synergies and the opportunity for the combined company to trade on NASDAQ. Initiated enrollment of healthcare professionals in ReShapeCare , the Company s first-in-class reimbursed, telehealth-based coaching program providing patients a tailored, high-touch, and personalized virtual treatment. Received funding from a National Institutes of Health (NIH) Small Business Innovation Research grant to identify and successfully meet the necessary endpoints of a pre-clinical study with ReShape s Dual Block Stimulation Neuromodulation (DBSN) technology currently in development for the treatment of type 2 diabetes.

James saliernoThomas stankovichTruth groupSmall business innovation researchObalon therapeutics incCompany contactNational institutes of healthExchange commissionLife sciences incReshape lifesciencesObalon therapeuticsNational institutesDual block stimulation neuromodulationBart bandyChief executive officerReshape vest